Previous close | 2.6200 |
Open | 2.6200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 70.00 |
Expiry date | 2024-05-17 |
Day's range | 2.6200 - 2.6200 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.
New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position BMRN, BPMC, IMVT, KYMR and LGND well amid volatility.
Agios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark, revenues from its sole marketed drug, Pyrukynd, rise sequentially and on a yearly basis.